The DOI matches its Crossref record.
Third generation oral contraceptives and risk of myocardial infarction: an international case-control study
Open accessAbstract
Abstract Objective: To test whether use of combined oral contraceptives containing third generation progestogens is associated with altered risk of myocardial infarction. Design: Matched case-control study. Setting: 16 centres in Austria, France, Germany, Switzerland, and the United Kingdom. Subjects: Cases were 153 women aged 16-44 with a myocardial infarction event. Controls were 498 women (at least 3 controls per case) unaffected by myocardial infarction who were matched with their corresponding case for age and for hospital or community setting within four months of the index infarction. Main outcome measures: Odds ratios derived with stratified analyses and unconditional logistic regression to adjust for potential confounding variables. Results: The estimated odds ratio for myocardial infarction of third compared with second generation oral contraceptives among all 651 study subjects was 0.36 (95% confidence interval 0.1 to 1.2) (P=0.11). The odds ratio for the United Kingdom and Germany alone was 0.45 (0.1 to 1.8) (P=0.26). Other odds ratios for the five countries were 3.1 (1.5 to 6.3) (P=0.003) for use of second generation products v no current use and 1.1 (0.4 to 3.4) (P=0.9) for use of third generation products v no current use. Among the confounding variables the independent contribution of smoking (for which adjustment was made in the above estimates) proved to be important (10.1 (5.7 to 17.9), P<0.001). Conclusion: An odds ratio of 0.45 with wide confidence intervals shows that third generation oral contraceptives compared with second generation products are associated with a reduced risk of myocardial infarction or with no difference. This finding from an interim analysis should be interpreted with extreme caution. However, the excess risk of venous thromboembolism associated with the use of third generation products may be balanced by the reduced risk of myocardial infarction associated with the same products. Key messages Key messages Compared with the results of British studies published in the 1970s, the risk of myocardial infarction among current users v non-users of second generation oral contraceptives was low The risk of myocardial infarction was appreciably lower among women using third generation products, the risk being comparable to that among women who did not use oral contraception and two to three times lower than that among women using second generation products The results suggest that about 12 fewer deaths from myocardial infarction in England and Wales and 46 fewer in Germany would occur each year if all those taking second generation oral contraceptives started taking third generation products Both the risks and the benefits of oral contraceptives need to be considered in a balanced way so that doctors can give judicious advice and women have informed choice
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The UK General Practice Research Database
Walley, T., & Mantgani, A. (1997) · The Lancet · doi:10.1016/s0140-6736(97)04248-7 · Cited by 623
Oral Contraceptives and the Risk of Myocardial Infarction
Tanis, B. C., van den Bosch, M. A. A. J., Kemmeren, J. M., Cats, V. M., Helmerhorst, F. M., Algra, A., van der Graaf, Y., & Rosendaal, F. R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa003216 · Cited by 367
Combined oral contraceptives: the risk of myocardial infarction and ischemic stroke
Roach, R. E. J., Helmerhorst, F. M., Lijfering, W. M., Stijnen, T., Algra, A., & Dekkers, O. M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011054.pub2 · Cited by 299
Oral contraceptive use and increased plasma concentration of C-reactive protein
Dreon, D. M., Slavin, J. L., & Phinney, S. D. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00425-9 · Cited by 75
Metadata
- Authors
- Lewis, M. A., Spitzer, W. O., Heinemann, L. A. J., MacRae, K. D., Bruppacher, R., & Thorogood, M.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1996-01-13
- Volume
- 312
- Issue
- 7023
- Pages
- 88-90
- ISSN
- 0007-1447 (ISSN-L)
- 0959-8138
- 1468-5833
- OpenAlex
- W2281667570
- Cited by
- 159
- References
- 0
- FWCI
- 42.06
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Third generation oral contraceptives and risk of myocardial infarction: an international case-control study. https://app.cochat.ai/papers/10.1136/bmj.312.7023.88
- The paper
- Lewis, M. A., Spitzer, W. O., Heinemann, L. A. J., MacRae, K. D., Bruppacher, R., & Thorogood, M. (1996). Third generation oral contraceptives and risk of myocardial infarction: an international case-control study. BMJ. https://doi.org/10.1136/bmj.312.7023.88
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.